Business Description

Apollo Hospitals Enterprise Ltd
ISIN : INE437A01024
Share Class Description:
NSE:APOLLOHOSP: Ordinary SharesCompare
Compare
Traded in other countries / regions
APOLLOHOSP.IndiaAPHOS.Luxembourg IPO Date
1996-01-10Description
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. The firm receives the most proportion of revenue from its core healthcare business. The firm's standalone pharmacy segment contributes the second largest proportion of revenue.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.7 | |||||
Debt-to-EBITDA | 2.04 | |||||
Interest Coverage | 4.43 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.43 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.6 | |||||
3-Year EBITDA Growth Rate | 4.8 | |||||
3-Year EPS without NRI Growth Rate | 20.3 | |||||
3-Year FCF Growth Rate | -32.5 | |||||
3-Year Book Growth Rate | 21.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 14.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.18 | |||||
9-Day RSI | 60.08 | |||||
14-Day RSI | 57.82 | |||||
6-1 Month Momentum % | 11.81 | |||||
12-1 Month Momentum % | 11.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 17.22 | |||||
Days Sales Outstanding | 43.38 | |||||
Days Payable | 77.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Dividend Payout Ratio | 0.38 | |||||
3-Year Dividend Growth Rate | 24.3 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.44 | |||||
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 0.33 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.91 | |||||
Operating Margin % | 8.49 | |||||
Net Margin % | 3.92 | |||||
ROE % | 11.26 | |||||
ROA % | 4.81 | |||||
ROIC % | 8.5 | |||||
ROC (Joel Greenblatt) % | 17.9 | |||||
ROCE % | 13.54 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 110.47 | |||||
Forward PE Ratio | 63.69 | |||||
PE Ratio without NRI | 110.47 | |||||
Shiller PE Ratio | 152.22 | |||||
Price-to-Owner-Earnings | 95.64 | |||||
PEG Ratio | 5.16 | |||||
PS Ratio | 4.33 | |||||
PB Ratio | 11.92 | |||||
Price-to-Tangible-Book | 14.47 | |||||
Price-to-Free-Cash-Flow | 297.63 | |||||
Price-to-Operating-Cash-Flow | 53.66 | |||||
EV-to-EBIT | 52.12 | |||||
EV-to-Forward-EBIT | 40.33 | |||||
EV-to-EBITDA | 36.53 | |||||
EV-to-Forward-EBITDA | 30.06 | |||||
EV-to-Revenue | 4.54 | |||||
EV-to-Forward-Revenue | 4 | |||||
EV-to-FCF | 312.17 | |||||
Price-to-Projected-FCF | 6.37 | |||||
Price-to-DCF (Earnings Based) | 7.92 | |||||
Price-to-DCF (FCF Based) | 25.79 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.42 | |||||
Price-to-Graham-Number | 7.62 | |||||
Earnings Yield (Greenblatt) % | 1.92 | |||||
Forward Rate of Return (Yacktman) % | 20.73 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apollo Hospitals Enterprise Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 170,670 | ||
EPS (TTM) (₹) | 46.51 | ||
Beta | 0.52 | ||
Volatility % | 18.12 | ||
14-Day RSI | 57.82 | ||
14-Day ATR (₹) | 100.863892 | ||
20-Day SMA (₹) | 5034.965 | ||
12-1 Month Momentum % | 11.08 | ||
52-Week Range (₹) | 4123 - 5364 | ||
Shares Outstanding (Mil) | 143.78 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Apollo Hospitals Enterprise Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Apollo Hospitals Enterprise Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Apollo Hospitals Enterprise Ltd Frequently Asked Questions
What is Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP)'s stock price today?
The current price of NSE:APOLLOHOSP is ₹5137.75. The 52 week high of NSE:APOLLOHOSP is ₹5364.00 and 52 week low is ₹4123.00.
When is next earnings date of Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP)?
The next earnings date of Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP) is .
Does Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP) pay dividends? If so, how much?
The Dividend Yield %  of Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP) is 0.29% (As of Today), Highest Dividend Payout Ratio of Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP) was 0.71. The lowest was 0.04. And the median was 0.28. The  Forward Dividend Yield % of Apollo Hospitals Enterprise Ltd(NSE:APOLLOHOSP) is 0.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |